Ganglioside GM2-activator protein and vesicular transport in collecting duct intercalated cells

Citation
Tm. Mundel et al., Ganglioside GM2-activator protein and vesicular transport in collecting duct intercalated cells, J AM S NEPH, 10(3), 1999, pp. 435-443
Citations number
35
Categorie Soggetti
Urology & Nephrology","da verificare
Journal title
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
ISSN journal
10466673 → ACNP
Volume
10
Issue
3
Year of publication
1999
Pages
435 - 443
Database
ISI
SICI code
1046-6673(199903)10:3<435:GGPAVT>2.0.ZU;2-U
Abstract
This study describes the molecular characterization of an antigen defined b y an autoantibody from a woman with habitual abortion as GM2-activator prot ein. The patient showed no disorder of renal function. Accidentally with ro utine serum screening for autoantibodies, an immunoreactivity was found in kidney collecting duct intercalated cells. Three distinct patterns of immun ostaining of intercalated cells were observed: staining of the apical pole, basolateral pole, and diffuse cytoplasmic labeling. Ultrastructurally, the immunoreactivity was associated with "studs," which represent the cytoplas mic domain of the vacuolar proton pump in intercalated cells. This pump is subjected to a shuttling mechanism from cytoplasmic stores to the cell memb rane, which exclusively occurs in intercalated cells. Peptide sequences of a 23-kD protein purified from rat kidney cortex showed complete identity wi th corresponding sequences of GM2-activator protein. In the brain, GM2-acti vator protein is required for hexosaminidase A to split a sugar from gangli oside GM2. Because neither ganglioside GM2 nor GM1 (its precursor) is prese nt in significant amounts in the kidney, the previous finding that this tis sue contains the highest level of activator protein in the body was confusi ng. In this study, a novel role for GM2-activator protein in intercalated c ells is proposed, and possible roles in the shuttling mechanism are discuss ed.